Exposés: Paris, 30, 31 mai et 1er juin 1989 1 Exposés du 30 mai 1989, après-midi
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Tagungsbericht Buch |
| Sprache: | Undetermined |
| Veröffentlicht: |
Paris
1989
|
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | 502 S. |
Internformat
MARC
| LEADER | 00000nam a2200000 cc4500 | ||
|---|---|---|---|
| 001 | BV004127538 | ||
| 003 | DE-604 | ||
| 005 | 19901105 | ||
| 007 | t | ||
| 008 | 901030s1989 |||| 10||| undod | ||
| 035 | |a (OCoLC)165494059 | ||
| 035 | |a (DE-599)BVBBV004127538 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | |a und | ||
| 049 | |a DE-12 | ||
| 111 | 2 | |a Congrès International de Technologie Pharmaceutique |n 5 |d 1989 |c Paris |j Verfasser |0 (DE-588)1219835-3 |4 aut | |
| 245 | 1 | 0 | |a Exposés |b Paris, 30, 31 mai et 1er juin 1989 |n 1 |p Exposés du 30 mai 1989, après-midi |c 5ème Congrès International de Technologie Pharmaceutique |
| 264 | 1 | |c 1989 | |
| 264 | 1 | |a Paris | |
| 300 | |a 502 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 773 | 0 | 8 | |w (DE-604)BV004127537 |g 1 |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002576267&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-002576267 | ||
Datensatz im Suchindex
| _version_ | 1804118344070070272 |
|---|---|
| adam_text | IMAGE 1
5EME CONGRES INTERNATIONAL
DE TECHNOLOGIE PHARMACEUTIQUE
5,H INTERNATIONAL CONFERENCE
ON PHARMACEUTICAL TECHNOLOGY
EXPOSESDU 30 MA11989, APRES-MIDI
PAPERSON 30 MAY 1989, AFTERNOON
PARIS 30, 31 MAI ET 1-JUIN 1989
PARIS 30, 31 MAY AND 1 JUNE 1989
TIB/UB HANNOVER 89 129 609 226
IMAGE 2
8
MARDI, 30 MAI 1989, APRES-MIDI/TUESDAY, 30 MAY 1989, AFTERNOON
AMPHITHEATRE 1 FORMES NOUVELLES/NEW DOSAGE FORMS PAGE
14.00 STUDIES ON BUCCOADHESIVE TABLET FORMULATION OF CODEINE PHOSPHATE
K.V. RANGA RAO, A. BEN-AMOR AND P. BURI 15
14.20 VARIOUS APPLICATIONS OF AN APPARATUS DETERMINING IN VITRO THE
RESULTANT-FORCE ACTING ON A PHARMACEUTICAL DOSAGE FORM IMMERSED IN A
FLUID J. TIMMERMANS AND AJ. MOES 22
14.40 A NOVEL ORAL USE BO CONTROLLED RELEASE FLOATING TABLET
X.-D.TUANDZ.-Y. HUA 32
15.00 PAUSE
15.20 ASSESSING BY GAMMA SCINTIGRAPHY THE IN VIVO BUOYANCY OF DOSAGE
FORMS HAVING KNOWN SIZE AND FLOATING FORCE PROFILES AS A FUNCTION OF
TIME
J. TIMMERMANS, B. VAN GANSBEKE AND A J. MOES 42
15.40 IMPROVED OCULAR DELIVERY OF PILOCARPINEAND TIMOLOL THROUGH
PRODRUGS H. BUNDGAARD 52
16.00 FORMULATION ET EVALUATION IN VITRO PUIS IN VIVO D UN INSERT DE
CHLORHYDRATE DE MORPHINE EN VUE DU PASSAGE OPHTALMOSYSTEMIQUE DE LA
MORPHINE G. DUMORTIER, M. ZUBER, F. CHAST, P. SANDOUK
ET J.-C. CHAUMEIL 61
16.20 NOUVELLE TECHNOLOGIEPOUR LA PREPARATION DE SYSTEMES MEDICAMENTEUX
MICROPARTICULAIRES A USAGE OPHTALMIQUE H. IBRAHIM,R. GURNY, C.
BINDSCHAEDLER ET P. BURI 70
16.40 PAUSE
17.00 NEW OPHTHALMIC DRUG RELEASE SYSTEMS, FORMULATION AND OCULAR
DISPOSITIONOF AMIKACIN-LOADED NANOPARTICLES MJ. ALONSO, C. LOSA, B.
SEIJO, D. TORRES AND J.-L. VILA-JATO 77
IMAGE 3
9
17.20 ETUDEDE LA BIODISPONIBILITE DU TETRACOSACTIDE (ACTH1.24) APRES
ADMINISTRATION INTRANASALE CHEZ LE RAT P. WUTHRICH, M. MARTENET ET P.
BURI 84
17.40 ABSORPTION OF FIBROBLAST INTERFERON-B IN POWDER DOSAGE FORM FROM
NASAL MUCOSA IN RABBITS T. NAGAI, Y. MAITANI AND N. UCHIDA 91
MARDI, 30 MAI 1989, APRES-MIDI/TUESDAY, 30 MAY 1989, AFTERNOON
AMPHITHEATRE 2 VOIE DERMIQUE, EMULSIONS DERMAL ROUTE, EMULSIONS PAGE
1400 INCORPORATION AND DIFFUSION OF MESOGENICDRUG MOLECULES IN A LIQUID
CRYSTALLINE LECITHIN VEHICLE AS DEMONSTRATEDWITH FENOPROFEN H.-J. HAMANN
AND C.C. MIILLER-GOYMANN 99
14.20 THE USE OFMEMBRANE MODELS FOR DESCRIBING THE TRANSDERMAL FLUX OF
DRUGS
B.ZIERENBERG 110
14.40 PREFORMULATION AND EVALUATION OFFURAZOLIDONE OINTMENTS A.M.
EL-SAYED, S. SHAWKY-TOUSAND S.I. ABDEL-RAHMAN 117
15.00 PAUSE
15.20 FORMULATION AND EVALUATION OF SOME TOPICAL ANTIMYCOTICS, 4
GRISEOFULVIN OINTMENT S.A. IBRAHIM, E. HAFEZ, S.M. EL-SHANAWANY, I.S.
EL-GIBALY, E.A. MOHAMED AND S.S. ALI 128
15.40 FORMULATION AND EVALUATION OF SOME TOPICAL ANTIMYCOTICS, 5
GRISEOFULVIN/CLOTRIMAZOLE OINTMENT COMBINATION S.A. IBRAHIM, E. HAFEZ,
S.M. EL-SHANAWANY, I.S. EL-GIBALY, E.A. MOHAMED AND S.S. ALI 138
16.00 INFLUENCE DE LA NATURE DE L AGENT DE SURFACE DANS LA FORMULATION
DES MICROEMULSIONS
M. DERONI ET M.-C. POELMAN 148
16.20 EFFECT OF FORMULATION ADDITIVES ON THE STABILITY OF A LIQUID
MULTIPLE EMULSION DELIVERY SYSTEM G.H. CUEMAN AND J.L. ZATZ 155
IMAGE 4
10
16.40 PAUSE
17.00 ETUDE ET MISE EN EVIDENCE DES EMULSIONS MULTIPLES L/H/L PAR
RESONANCE MAGNETIQUE NUCLEAIRE A. RABARON, P.A. ROCHA-FILHO, C. VAUTION
ET M. SEILLER 162
17.20 ETUDES DES MECANISMES DE LIBERATION D UN PRINCIPE ACTIF ENTRE LES
PHASES AQUEUSES INTERNE ET EXTERNE D UNE EMULSION TRIPLE H/L/H J.L.
GROSSIORD, M. DE LUCA, J.M. MEDARD, C. VAUTION ET M. SEILLER 172
17.40 CONNAISSANCE EXACTE DE LA DIFFUSION D UN PRINCIPE ACTIF AU SEIN DE
MATRICES POLYMERIQUES PAR L ANALYSEDE RADIOCHROMATOGRAMMES DE
CONCENTRATION G. COUARRAZE, G. CONRATH, B. LECLERC ET F. FALSON-RIEG 182
MARDI, 30 MAI 1989, APRES-MIDI/TUESDAY, 30 MAY 1989, AFTERNOON
AMPHITHEATRE 5 POUDRES/POWDERS PAGE
14.00 CRYSTALLINITY AND RELATED PHARMACEUTICAL PROPERTIES Y. NAKAI AND
K. YAMAMOTO 192
14.20 INVESTIGATION ON THE STRUCTUREOFPOWDERED CELLULOSE M. BAEHR AND C.
FUHRER 201
14.40 ETUDE DE DIFFERENTES FORMES POLYMORPHES DU MEPROBAMATE C.
LEFEBVRE, F. GUILLAUME, R. BOUCHE, R. BOUAZIZ ETJ.-C. GUYOT 211
15.00 PAUSE
15.20 POSSIBILITES D ERREUR D INTERPRETATION DES DIAGRAMMES D ANALYSE
THERMIQUE DES SUBSTANCES POLYMORPHES, EXEMPLEDU SULFABENZAMIDE
E. DOELKER, D. MORDIER ET F. KUBEL 222
15.40 THERMAL BEHAVIOUR AND PHASE DIAGRAMS OFSOBREROL ENANTIOMERS AND
RACEMATES GJP. BETTINETTI, F. GIORDANO, A. ITALIA, R. PELLEGATA AND P.
VENTURA 232
IMAGE 5
11
16.00 TRAITEMENT DES ISOTHERMES D ADSORPTION DE L EAU SUR L AVICEL PH
101 ET LE FRACTOSIL 5000 OBTENUES PAR LA CHROMATOGRAPHIC EN ANALYSE
FRONTALE SELON LES MODELES BET, GAB ET HAILWOOD-HORROBIN
VOVAN NHUAN, P. RUELLE, J.C. NEGRE, M. BUCHMANN, HO NAM TRAN ETU.W.
KESSELRING 241
16.20 MONOLAYER ADSORPTION OF SURFACTANTS ON DRUG CRYSTALS AND ITS
POTENTIAL FOR MODIFYINGPOWDER PROPERTIES B. GANDERANDN.B. GRAHAM 251
16.40 PAUSE
17.00 STRUCTURAL ANALYSIS OF POLY(VINYL ALCOHOL) CROSS-LINKED BY GAMMA
IRRADIATION IN THE PRESENCE OFCOSOLUTES, POSSIBILITIES AND LIMITATIONS
IN FORMULATION
B. GANDER, R. GURNY AND E. DOELKER 261
17.20 APPLICATION DES SERIES TEMPORELLES A L ETUDE DU MELANGE DES
POUDRES A PRINCIPE ACTIF COHESIF ET TRES FAIBLEMENT DOSE L.H. CARTILIER
ET AJ. MOES 268
17.40 THE USEFULNESS OF ORDERED MIXTURES IN DRUG FORMULATION OF A
SOLID DOSAGE FORM M. WESTERBERG AND C. NYSTROM 278
MARDI, 30 MAI 1989, APRES-MIDI/TUESDAY, 30 MAY 1989, AFTERNOON
POSTERS ACTION PROLONGEE, BIODISPONIBILITE, ENROBAGE, FILMS, DIVERS
SUSTAINED RELEASE, BIOAVAILABILITY, COATING, FILMS, MISCELLANEOUS PAGE
INFLUENCE OF THEAMOUNTOFGRANULATION FLUIDON THE RELEASE RATE
OF5-AMINOSALICYLIC ACID FROM MATRIX PELLETS CONTAINING MICROCRYSTALLINE
CELLULOSEAND
SODIUM CARBOXYMETHYLCELLULOSE V. DE BRANT AND J.P. REMON
288
MISEAU POINT D UN BOLUS OVIN A LIBERATION PROLONGEE B. EVRARD, J.-P.
DECHESNE, X. FARGETTON, N. ZYGRAICH ET L. DELATTRE 294
SYSTEME MATRICIEL BIORESORBABLE POUR LA DELIVRANCE DE POLYPEPTIDES,
APPLICATION A LA SUPEROVULATION BOVINE M. DEMOUSTIER, J.F. BECKERS, M.
VERT, H. TAPER ET J. GILLARD 301
IMAGE 6
12
SYSTEME MATRICIEL POLYMERIQUE INDUISANT UNE LIBERATION A LONG TERME,
APPLICATION A LA MALARIA M. TSAKALA, M. VERT, R. LEGRAS ET J. GILLARD
307
QUANTITATIVE APPLICATION OF HIGUCHI S RELATIONSHIP TO EUDRAGIT
(METHYLACRYLATE/METHYL METHACRYLATE COPOLYMER) AND EDIYL CELLULOSE
MATRICES FORNSAIDS N.N. CHUGH AND S.G. DESHPANDE 317
DEVELOPMENTOF MONOLITH CONTROLLED DRUG DELIVERY SYSTEMS BY SINTERING OF
POLYMER MATRIX M. NESIC 326
AN IN VITRO ABSORPTION MODEL WITH A CELL MONOLAYER B. SCHMID, H.
LEUENBERGERAND C. REINKE 335
BIOAVAILABILITY IN HUMANS OF A NEW ORALDOSAGE FORM OF SOLUBLE IBUPROFEN
F. STROPPOLO, V. GIANESELLO, E. BRENN AND A. GAZZANIGA 342
THE DISCREPANCY BETWEEN PHARMACOP*IAL DISSOLUTION TESTSAND
BIOAVAILABILITY OF DICLOFENAC SODIUM SUSTAINED RELEASE TABLETS J.C.
BAIN, S.B. TAN, D. GANDERTON AND M.C. SOLOMON 349
SUSTAINED RELEASE ISONIAZID TABLETS, 1 FORMULATION AND IN VITRO
EVALUATION F. BULUT-ONER, T. CAPAN, S. KAS, L. ONER AND A.A. HINCAL 356
SUSTAINED RELEASE ISONIAZID TABLETS, 2 IN VIVO EVALUATION Y. CAPAN, S.
KAS, L. ONER, F. BULUT-ONER AND A.A. HINCAL 366
IN VITRO RELEASE KINETICS AND PHARMACOKINETICS OF NIFEDIPINE FROM
CONTROLLED RELEASE GRANULES S.E. LEUCUTA 371
ETUDE COMPARATIVEDE DIVERSES SPECIALITESDE CHLORURE DE POTASSIUM A
LIBERATION PROLONGEE, ESSAIS DE DISSOLUTION IN VITRO P. MULLER, C.S.
QIAO, J.-Y. PABST ET A. STAMM 380
BIODISPONIBILITE DU PARACETAMOL SELON LA FORME PHARMACEUTIQUE APRES
ADMINISTRATION ORALE
G. PEYTAVIN, H. RAZAFINDRAKOTO, J.L. PARIER, O. PICARD, L. BONHOMME, G.
FREDJ, J. RINGARD ET C. GLUCK 390
STUDIES ON SUSTAINED-RELEASE ZINC SULPHATE DOSAGE FORMS L.-H. ZHANG,
F.-F. MAO AND X.-D. TU 399
DEVELOPMENTAND PHARMACOKINETIC STUDY OF SUSTAINED RELEASE IBUPROFEN
PELLETS X.-D. TU, B. WANG, Z.-D. LU AND J.-B. ZHU 407
IMAGE 7
13
AQUEOUS-BASED ENTERIC FILM COATINGS CONTAINING INSOLUBLE ADDITIVES R.
BIANCHINI, M. RESCINITI AND C. VECCHIO 416
THE ENHANCEMENT EFFECT OF SURFACTANTS ON THE RELEASE OF TETRACYCLINE
FROM ETHYLCELLULLOSE FILM R. ELKAYAM, R. AZOURY, A. STABHOLZ AND M.
FRIEDMAN 426
ADAPTED SPRAY-DRYING METHOD FOR THE PRODUCTIONOFVERY FINE PHARMACEUTICAL
POWDERS STARTINGFROM NON-AQUEOUS SOLUTIONS L. RODRIGUEZ, M. CINI AND R.
MONGIORGI 434
ACCELERATION OF FREEZE-DRYING CYCLES OFAQUEOUS SOLUTIONS OFLACTOSE AND
SUCROSE WITH TERTIARY BUTYL ALCOHOL P.P. DELUCA,M.S. KAMAT AND Y. KOIDA
439
EFFECTOF FORMULATION ADDITIVESON THE DEGRADATIONOFFREEZE-DRIED
RIBONUCLEASE A
P.P. DELUCA, M. TOWNSEND AND P. BYRON 448
STABILITYOFRIBONUCLEASE A IN SOLUTIONAND THE FREEZE-DRIED STATE
P.P. DELUCAAND M. TOWNSEND 457
ETUDE DES PARAMETRES D EXECUTION D UNE LYOPHILISATION L. BAUVAL, G.
CAVE, G. COUARRAZE, Y. BENSOUDA ET F. PUISIEUX 466
A STUDY OF THE POSSIBILITIES OF PREPARING SOME NEW MEDICINES BASED ON
MAGNESIUM SALTS A. POPOVICI, I. PAPP AND B. TOKES 476
MICELLAR SOLUBILIZATION OF BARBITURIC ACIDS IN BINARY SURFACTANT
SYSTEMS,
A REGULAR SOLUTION APPROACH C. TREINER, M. NORTZ, C. VAUTION AND F.
PUISIEUX 482
STABLE SUCRALFATE SUSPENSIONS FREE OF SUSPENDING AGENTS C. CARAMELLA, U.
CONTE AND P. COLOMBO 492
QUALITYIMPROVEMENT BY OPTIMIZATION OF THE IN-PROCESS CONTROLS
J.-C. TRITSCH AND F. BRINER
500
|
| any_adam_object | 1 |
| author_corporate | Congrès International de Technologie Pharmaceutique Paris |
| author_corporate_role | aut |
| author_facet | Congrès International de Technologie Pharmaceutique Paris |
| author_sort | Congrès International de Technologie Pharmaceutique Paris |
| building | Verbundindex |
| bvnumber | BV004127538 |
| ctrlnum | (OCoLC)165494059 (DE-599)BVBBV004127538 |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01091nam a2200277 cc4500</leader><controlfield tag="001">BV004127538</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19901105 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">901030s1989 |||| 10||| undod</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)165494059</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV004127538</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">und</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="111" ind1="2" ind2=" "><subfield code="a">Congrès International de Technologie Pharmaceutique</subfield><subfield code="n">5</subfield><subfield code="d">1989</subfield><subfield code="c">Paris</subfield><subfield code="j">Verfasser</subfield><subfield code="0">(DE-588)1219835-3</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Exposés</subfield><subfield code="b">Paris, 30, 31 mai et 1er juin 1989</subfield><subfield code="n">1</subfield><subfield code="p">Exposés du 30 mai 1989, après-midi</subfield><subfield code="c">5ème Congrès International de Technologie Pharmaceutique</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1989</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Paris</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">502 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="w">(DE-604)BV004127537</subfield><subfield code="g">1</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002576267&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-002576267</subfield></datafield></record></collection> |
| id | DE-604.BV004127538 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T16:08:48Z |
| institution | BVB |
| institution_GND | (DE-588)1219835-3 |
| language | Undetermined |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-002576267 |
| oclc_num | 165494059 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | 502 S. |
| publishDate | 1989 |
| publishDateSearch | 1989 |
| publishDateSort | 1989 |
| record_format | marc |
| spelling | Congrès International de Technologie Pharmaceutique 5 1989 Paris Verfasser (DE-588)1219835-3 aut Exposés Paris, 30, 31 mai et 1er juin 1989 1 Exposés du 30 mai 1989, après-midi 5ème Congrès International de Technologie Pharmaceutique 1989 Paris 502 S. txt rdacontent n rdamedia nc rdacarrier (DE-604)BV004127537 1 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002576267&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Exposés Paris, 30, 31 mai et 1er juin 1989 |
| title | Exposés Paris, 30, 31 mai et 1er juin 1989 |
| title_auth | Exposés Paris, 30, 31 mai et 1er juin 1989 |
| title_exact_search | Exposés Paris, 30, 31 mai et 1er juin 1989 |
| title_full | Exposés Paris, 30, 31 mai et 1er juin 1989 1 Exposés du 30 mai 1989, après-midi 5ème Congrès International de Technologie Pharmaceutique |
| title_fullStr | Exposés Paris, 30, 31 mai et 1er juin 1989 1 Exposés du 30 mai 1989, après-midi 5ème Congrès International de Technologie Pharmaceutique |
| title_full_unstemmed | Exposés Paris, 30, 31 mai et 1er juin 1989 1 Exposés du 30 mai 1989, après-midi 5ème Congrès International de Technologie Pharmaceutique |
| title_short | Exposés |
| title_sort | exposes paris 30 31 mai et 1er juin 1989 exposes du 30 mai 1989 apres midi |
| title_sub | Paris, 30, 31 mai et 1er juin 1989 |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002576267&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV004127537 |
| work_keys_str_mv | AT congresinternationaldetechnologiepharmaceutiqueparis exposesparis3031maiet1erjuin19891 |